Bohring-Opitz Syndrome

Oncology·MeSH: Spinocerebellar ataxia 8

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Bohring-Opitz Syndrome?

There are 1 clinical trial targeting Bohring-Opitz Syndrome tracked by BioSniper.

What is the prevalence of Bohring-Opitz Syndrome?

The estimated prevalence of Bohring-Opitz Syndrome is approximately 0.1 per 100,000 population.

Deep-dive into Bohring-Opitz Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Bohring-Opitz Syndrome — Drugs in Development & Clinical Trials | BioSniper